Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
5.045
+0.18
(+3.81%)
USD |
NASDAQ |
Oct 26, 16:00
5.14
+0.10
(+1.88%)
After-Hours: 20:00
Shuttle Pharmaceuticals Holdings Net Income (Quarterly) : -3.146M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.146M |
| March 31, 2026 | -2.152M |
| December 31, 2025 | -2.615M |
| September 30, 2025 | -2.347M |
| June 30, 2025 | -3.706M |
| March 31, 2025 | -3.053M |
| December 31, 2024 | -1.598M |
| September 30, 2024 | -3.784M |
| June 30, 2024 | -2.031M |
| March 31, 2024 | -1.731M |
| December 31, 2023 | -1.640M |
| Date | Value |
|---|---|
| September 30, 2023 | -1.793M |
| June 30, 2023 | -2.184M |
| March 31, 2023 | -0.9751M |
| December 31, 2022 | -0.7509M |
| September 30, 2022 | -0.9984M |
| June 30, 2022 | -0.5973M |
| March 31, 2022 | -0.6818M |
| December 31, 2021 | -0.459M |
| September 30, 2021 | -0.217M |
| June 30, 2021 | -0.3468M |
| March 31, 2021 | -0.1293M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.146M |
| EPS Diluted (Quarterly) | -3.098 |
| Enterprise Value | 5.156M |
| Earnings Yield | -610.6% |
| Normalized Earnings Yield | -632.99 |